CAR T-Cells for CNS Lymphoma: Driving into New Terrain?

SIMPLE SUMMARY: Primary or secondary central nervous system (CNS) lymphoma is frequently associated with a poor prognosis. CAR T-cells are being established as a relevant treatment approach in hematological B-cell malignancies. Unfortunately, most clinical studies on chimeric antigen-receptor (CAR)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Karschnia, Philipp, Blobner, Jens, Teske, Nico, Schöberl, Florian, Fitzinger, Esther, Dreyling, Martin, Tonn, Joerg-Christian, Thon, Niklas, Subklewe, Marion, von Baumgarten, Louisa
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161128/
https://ncbi.nlm.nih.gov/pubmed/34065471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102503
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados